{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:58:40Z","timestamp":1762430320473},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1157\/13128779","type":"journal-article","created":{"date-parts":[[2008,11,22]],"date-time":"2008-11-22T12:56:56Z","timestamp":1227358616000},"page":"38-46","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S13","title":["Avances en el diagn\u00f3stico y tratamiento de las infecciones por levaduras: papel de los nuevos antif\u00fangicos"],"prefix":"10.1016","volume":"26","author":[{"given":"Javier","family":"Pem\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benito","family":"Almirante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13128779_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"10.1157\/13128779_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1086\/520192","article-title":"Nosocomial bloodstream infections in United States hospitals: a three-year analysis","volume":"29","author":"Edmond","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13128779_bib3","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1086\/378745","article-title":"Attributable mortality of nosocomial candidemia, revisited","volume":"37","author":"Gudlaugsson","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13128779_bib4","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1086\/514955","article-title":"The impact of candidemia on length of hospital stay, outcome, and overall cost of illness","volume":"27","author":"Rentz","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13128779_bib5","series-title":"Gu\u00eda pr\u00e1ctica de identificaci\u00f3n y diagn\u00f3stico en micolog\u00eda cl\u00ednica","article-title":"Diagn\u00f3stico microsc\u00f3pico de las micosis","author":"Llovo","year":"2007"},{"key":"10.1157\/13128779_bib6","series-title":"Gu\u00eda pr\u00e1ctica de identificaci\u00f3n y diagn\u00f3stico en micolog\u00eda cl\u00ednica","first-page":"6.1","article-title":"Procesamiento de las muestras de sangre, l\u00edquidos est\u00e9riles y tejidos","author":"Pem\u00e1n","year":"2007"},{"key":"10.1157\/13128779_bib7","series-title":"Gu\u00eda pr\u00e1ctica de identificaci\u00f3n y diagn\u00f3stico en micolog\u00eda cl\u00ednica","first-page":"11.20","article-title":"Identificaci\u00f3n de levaduras","author":"Linares","year":"2007"},{"key":"10.1157\/13128779_bib8","first-page":"82","article-title":"Rapid identification of Candida glabrata using a new commercial kit","volume":"21","author":"Pem\u00e1n","year":"2004","journal-title":"Rev Iberoam Micol"},{"key":"10.1157\/13128779_bib9","series-title":"Gu\u00eda pr\u00e1ctica de identificaci\u00f3n y diagn\u00f3stico en micolog\u00eda cl\u00ednica","article-title":"Diagn\u00f3stico serol\u00f3gico de las micosis","author":"Ponton","year":"2007"},{"key":"10.1157\/13128779_bib10","first-page":"20","article-title":"Microbiological non-culture methods for the diagnosis of invasive candidiasis: usefulness of surrogate markers","volume":"23","author":"Ponton","year":"2006","journal-title":"Rev Iberoam Micol"},{"key":"10.1157\/13128779_bib11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0213-005X(04)73039-6","article-title":"Evaluation of a new commercial test (Candida albicans IFA IgG) for the serodiagnosis of invasive candidiasis","volume":"22","author":"Moragues","year":"2004","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1157\/13128779_bib12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1086\/421944","article-title":"Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome","volume":"39","author":"Odabasi","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13128779_bib13","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/432470","article-title":"Multicenter clinical evaluation of the (1\u21923) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans","volume":"41","author":"Ostrosky-Zeichner","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13128779_bib14","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1128\/JCM.43.12.5957-5962.2005","article-title":"Evaluation of a (1\u21923)-beta-D-glucan assay for diagnosis of invasive fungal infections","volume":"43","author":"Pickering","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13128779_bib15","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1128\/JCM.42.1.164-171.2004","article-title":"Increased sensitivity of mannanemia detection tests by joint detection of alpha-and beta-linked oligomannosides during experimental and human systemic candidiasis","volume":"42","author":"Sendid","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13128779_bib16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.femsim.2005.05.012","article-title":"Towards a molecular diagnosis of invasive aspergillosis and disseminated candidosis","volume":"45","author":"Bretagne","year":"2005","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1157\/13128779_bib17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1130-1406(06)70008-0","article-title":"Molecular biology in the diagnosis of deep-seated candidiasis in the critically ill non-neutropenic patient","volume":"23","author":"Colom","year":"2006","journal-title":"Rev Iberoam Micol"},{"key":"10.1157\/13128779_bib18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1130-1406(06)70046-8","article-title":"Diagnostic potential of (1,3)-beta-D-glucan and anti-Candida albicans germ tube antibodies for the diagnosis and therapeutic monitoring of invasive candidiasis in neutropenic adult patients","volume":"23","author":"Pazos","year":"2006","journal-title":"Rev Iberoam Micol"},{"key":"10.1157\/13128779_bib19","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1128\/JCM.43.5.2181-2187.2005","article-title":"Comparison of non-culture-based methods for detection of systemic fungal infections, with an emphasis on invasive Candida infections","volume":"43","author":"White","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13128779_bib20","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1517\/14656566.8.10.1479","article-title":"A comparative evaluation of properties and clinical efficacy of the echinocandins","volume":"8","author":"Kim","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1157\/13128779_bib21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000096348","article-title":"The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications","volume":"78","author":"Wagner","year":"2006","journal-title":"Pharmacology"},{"key":"10.1157\/13128779_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/tcrm.2007.3.1.71","article-title":"Comparison of echinocandin antifungals","volume":"3","author":"Eschenauer","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"10.1157\/13128779_bib23","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(03)14472-8","article-title":"Echinocandin antifungal drugs","volume":"362","author":"Denning","year":"2003","journal-title":"Lancet"},{"key":"10.1157\/13128779_bib24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/14787210.2.4.499","article-title":"Anidulafungin: review of a new echinocandin antifungal agent","volume":"2","author":"Raasch","year":"2004","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1157\/13128779_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1086\/505204","article-title":"Anidulafungin: a novel echinocandin","volume":"43","author":"V\u00e1zquez","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13128779_bib26","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1128\/AAC.49.11.4536-4545.2005","article-title":"Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents","volume":"49","author":"Walsh","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13128779_bib27","series-title":"45th Interscience Conference on Antimicrobial Agents and Chemotherapy (abstract LB-16)","article-title":"Pharmacokinetics (PK) of caspofungin (CAS) in six premature neonates (PNN) with invasive candidiasis (IC) at a neonatal intensive care unit (NNICU)","author":"Odio","year":"2005"},{"key":"10.1157\/13128779_bib28","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1128\/AAC.49.8.3317-3324.2005","article-title":"Safety, tolerability, and pharmacokinetics of micafungin (FK463) in febrile neutropenic pediatric patients","volume":"49","author":"Seibel","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13128779_bib29","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1128\/AAC.50.2.632-638.2006","article-title":"Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections","volume":"50","author":"Benjamin","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13128779_bib30","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1128\/AAC.49.12.5058-5068.2005","article-title":"Pharmacodynamics of caspofungin in a murine model of systemic candidiasis: importance of persistence of caspofungin in tissues to understanding drug activity","volume":"49","author":"Louie","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13128779_bib31","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.idc.2006.06.007","article-title":"Pharmacokinetics and pharmacodynamics of antifungals","volume":"20","author":"Andes","year":"2006","journal-title":"Infect Dis Clin North Am"},{"key":"10.1157\/13128779_bib32","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1128\/AAC.48.11.4306-4314.2004","article-title":"Potential for interactions between caspofungin and nelfinavir or rifampin","volume":"48","author":"Stone","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13128779_bib33","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1177\/0091270005279274","article-title":"Concomitant tacrolimus and micafungin pharmacokinetics in healthy volunteers","volume":"45","author":"Hebert","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"10.1157\/13128779_bib34","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/423378","article-title":"A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis","volume":"39","author":"Krause","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13128779_bib35","series-title":"39th Interscience Conference on Antimicrobial Agents and Chemotherapy (abstract 2003)","article-title":"Combination antifungal therapy with FK463 plus amphotericin B in treatment of experimental pulmonary aspergillosis","author":"Petraitis","year":"1999"},{"key":"10.1157\/13128779_bib36","series-title":"46th Interscience Conference on Antimicrobial Agents and Chemotherapy (abstract M-366)","article-title":"Digestion of Echinocandins","author":"Kelley","year":"2006"},{"key":"10.1157\/13128779_bib37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00126334-200210010-00009","article-title":"Efficacy of caspofungin in the treatment of esophageal candidiasis resistant to fluconazole","volume":"31","author":"Kartsonis","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1157\/13128779_bib38","series-title":"44th Interscience Conference on Antimicrobial Agents and Chemotherapy (abstract M-1038)","article-title":"Efficacy of anidulafungin in patients with azole-refractory mucosal candidiasis (ARMC)","author":"V\u00e1zquez","year":"2004"},{"key":"10.1157\/13128779_bib39","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1086\/496935","article-title":"Candidemia is costly\u2014plain and simple","volume":"41","author":"Fridkin","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13128779_bib40","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa021585","article-title":"Comparison of caspofungin and amphotericin B for invasive candidiasis","volume":"347","author":"Mora-Duarte","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1157\/13128779_bib41","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(07)60605-9","article-title":"Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial","volume":"369","author":"Kuse","year":"2007","journal-title":"Lancet"},{"key":"10.1157\/13128779_bib42","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1086\/520980","article-title":"Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis","volume":"45","author":"Pappas","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13128779_bib43","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.idc.2006.07.004","article-title":"Invasive candidiasis","volume":"20","author":"Pappas","year":"2006","journal-title":"Infect Dis Clin North Am"},{"key":"10.1157\/13128779_bib44","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/jac\/dkh179","article-title":"Second-line therapy with caspofungin for mucosal or invasive candidiasis: results from the caspofungin compassionate-use study","volume":"53","author":"Kartsonis","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1157\/13128779_bib45","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s10096-005-0024-8","article-title":"International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia","volume":"24","author":"Ostrosky-Zeichner","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1157\/13128779_bib46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2165\/00003495-200767020-00009","article-title":"Voriconazole: a review of its use in the management of invasive fungal infections","volume":"67","author":"Scott","year":"2007","journal-title":"Drugs"},{"key":"10.1157\/13128779_bib47","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1517\/14656566.6.7.1215","article-title":"Voriconazole: review of a broad spectrum triazole antifungal agent","volume":"6","author":"Kofla","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"10.1157\/13128779_bib48","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1128\/AAC.48.6.2166-2172.2004","article-title":"Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration","volume":"48","author":"Walsh","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13128779_bib49","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1586\/14787210.3.4.467","article-title":"Posaconazole: clinical pharmacology and potential for management of fungal infections","volume":"3","author":"Groll","year":"2005","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1157\/13128779_bib50","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.2165\/00003495-200565110-00007","article-title":"Posaconazole","volume":"65","author":"Keating","year":"2005","journal-title":"Drugs"},{"key":"10.1157\/13128779_bib51","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1128\/AAC.00454-06","article-title":"Posaconazole plasma concentrations in juvenile patients with invasive fungal infection","volume":"51","author":"Krishna","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13128779_bib52","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1086\/322653","article-title":"A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients","volume":"33","author":"Ally","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13128779_bib53","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0140-6736(05)67490-9","article-title":"Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial","volume":"366","author":"Kullberg","year":"2005","journal-title":"Lancet"},{"key":"10.1157\/13128779_bib54","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1086\/501457","article-title":"A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV\/AIDS","volume":"42","author":"V\u00e1zquez","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13128779_bib55","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease","volume":"356","author":"Ullmann","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1157\/13128779_bib56","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1157\/13128779_bib57","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1574-6976.2005.00001.x","article-title":"Fungal heat-shock proteins in human disease","volume":"30","author":"Burnie","year":"2006","journal-title":"FEMS Microbiol Rev"},{"key":"10.1157\/13128779_bib58","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/503428","article-title":"A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis","volume":"42","author":"Pachl","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13128779_bib59","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1086\/507547","article-title":"Mycograb for the treatment of invasive candidiasis","volume":"43","author":"Herbrecht","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13128779_bib60","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1128\/AAC.46.3.739-745.2002","article-title":"Single- and multiple-dose pharmacokinetics of caspofungin in healthy men","volume":"46","author":"Stone","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13128779_bib61","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1128\/AAC.49.4.1331-1336.2005","article-title":"Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant","volume":"49","author":"Hiemenz","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13128779_bib62","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1177\/0091270004265644","article-title":"Population pharmacokinetic analysis of anidulafungin, an echinocandin antifungal","volume":"44","author":"Dowell","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"10.1157\/13128779_bib63","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1086\/323401","article-title":"A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis","volume":"33","author":"Villanueva","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13128779_bib64","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/AAC.46.2.451-457.2002","article-title":"Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases","volume":"46","author":"Arathoon","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13128779_bib65","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0002-9343(02)01191-9","article-title":"A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis","volume":"113","author":"Villanueva","year":"2002","journal-title":"Am J Med"},{"key":"10.1157\/13128779_bib66","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1086\/423377","article-title":"A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients","volume":"39","author":"de Wet","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13128779_bib67","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1365-2036.2005.02427.x","article-title":"A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis","volume":"21","author":"de Wet","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13128779_bib68","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMoa066906","article-title":"Anidulafungin versus fluconazole for invasive candidiasis","volume":"356","author":"Reboli","year":"2007","journal-title":"N Engl J Med"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X08765819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X08765819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T00:57:45Z","timestamp":1545613065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X08765819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":68,"alternative-id":["S0213005X08765819"],"URL":"https:\/\/doi.org\/10.1157\/13128779","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}